The Swiss Register of Commerce registered the resolution. The stock split will be effective starting from March 29, 2016
March 24 2016 - 9:04AM
Italian Regulatory (Text)
Media Release of March 24, 2016
BB Biotech AG: The Swiss Register of Commerce registered the
resolution. The stock split will be effective starting from March
29, 2016
BB Biotech AG announces to have received confirmation that the
Swiss Register of Commerce registered the resolution on March 24,
2016. The 5-for-1 stock split, approved by the General Meeting on
March 17, 2016, will be effective starting from March 29, 2016. The
new shares par value will be 0.20 CHF.
Investor Relations Bellevue Asset Management AG, Seestrasse 16,
8700 Küsnacht, Switzerland, Tel. +41 44 267 67 00 Dr. Silvia
Schanz, ssc@bellevue.ch Maria-Grazia Iten-Alderuccio,
mga@bellevue.ch Claude Mikkelsen, cmi@bellevue.ch Media Relations
Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht,
Switzerland, Tel. +41 44 267 67 00 Tanja Chicherio, tch@bellevue.ch
b-public AG, Pfingstweidstrasse 6, 8005 Zurich, Switzerland, Tel.
+41 79 423 22 28 Thomas Egger, teg@b-public.ch
www.bbbiotech.com
Company profile BB BIOTECH invests in companies in the fast growing
market of biotechnology and is one of the world's largest investors
in this sector. BB Biotech is listed in Switzerland, Germany and
Italy. Its investments are focused on listed companies that are
developing and commercializing novel medical treatments and cures.
BB Biotech's investment selection process is guided by the
fundamental research and analysis of physicians and molecular
biologists. Its Board of Directors has many years of experience in
industry and science. Disclaimer This release contains
forward-looking statements and expectations as well as assessments,
beliefs and assumptions. Such statements are based on the current
expectations of BB Biotech, its directors and officers, and are,
therefore, subject to risks and uncertainties that may change over
time. As actual developments may significantly differ, BB Biotech
and its directors and officers accept no responsibility in that
regard. All forwardlooking statements included in this release are
made only as of the date of this release and BB Biotech and its
directors and officers assume no obligation to update any
forward-looking statements as a result of new information, future
events or other factors.
BB Biotech (BIT:BION)
Historical Stock Chart
From Jun 2024 to Jul 2024
BB Biotech (BIT:BION)
Historical Stock Chart
From Jul 2023 to Jul 2024